Kawazoe, Mai
Kaneko, Kaichi
Yamada, Zento
Masuoka, Shotaro
Mizutani, Satoshi
Yamada, Soichi
Shikano, Kotaro
Sato, Hiroshi
Kaburaki, Makoto
Muraoka, Sei
Kawai, Shinichi
Nanki, Toshihiro
Funding for this research was provided by:
Research expenses from Toho University School of Medicine. (none)
Article History
Received: 19 December 2018
Revised: 29 January 2019
Accepted: 7 February 2019
First Online: 18 February 2019
Compliance with ethical standards
:
: This study was approved by the Ethics Committee at Toho University Omori Medical Center (approval no. M17140) and was conducted in accordance with the principles of the Declaration of Helsinki and its later amendments, and Ethical Guidelines for medical research targeting people by Ministry of Health, Labour and Welfare of the Japanese Government.
: HS received speaker fee from Chugai Pharmaceutical Co., Ltd. SM received speaker fee from Chugai Pharmaceutical Co., Ltd., and Pfizer Japan Inc. SK received research grants from Astellas Pharma Inc., Ayumi Pharmaceutical Co., and Chugai Pharmaceutical Co., Ltd. TN received grant/research support from Chugai Pharmaceutical Co., Ltd., Astellas Pharma Inc., Ayumi Pharmaceutical Co., Pfizer Japan Inc., and Shionogi & Co., Ltd., consultant fees from Chugai Pharmaceutical Co., Ltd., and speaker fees from Chugai Pharmaceutical Co., Ltd., Astellas Pharma Inc., Ayumi Pharmaceutical Co., and Pfizer Japan Inc.